Skip to main content
. 2020 Apr 24;40(7):1516–1528. doi: 10.1111/liv.14468

FIGURE 2.

FIGURE 2

(A) The global seroprevalence of anti‐HEV IgG antibody (B) The global seroprevalence of anti‐HEV IgM antibody (C) The global prevelence of HEV RNA prositivity